Abstract
Background: The blood in the umbilical cord that provides the connection between mother and fetus during pregnancy is called cord blood. The blood of umbilical cord which is usually got rid of following birth, is a very rich stem cell source.
Objective: Cord blood collection gives no harm to the mother and baby. Besides, its allogeneic and autologous usage, the most important disadvantage is that the number of cells is insufficient in adults.
Conclusion: Today, it is predominantly used for therapeutic purposes for many diseases. The aim of this review is giving a detailed information about groups of stem cells in cord blood and determining the point of clinical use.
Keywords: Clinical use, cord blood, stem cell, umblical cord blood, patent, haematology, haemopoetic diseases.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title:Clinical Use and Patentability of Cord Blood
Volume: 11 Issue: 1
Author(s): Turker Cavusoglu*, Kubilay Dogan Kilic, Gurkan Yigitturk, Canberk Tomruk, Mehmet Turgut and Yigit Uyanikgil
Affiliation:
- Department of Histology and Embryology, Ege University School of Medicine, Izmir,Turkey
Keywords: Clinical use, cord blood, stem cell, umblical cord blood, patent, haematology, haemopoetic diseases.
Abstract: Background: The blood in the umbilical cord that provides the connection between mother and fetus during pregnancy is called cord blood. The blood of umbilical cord which is usually got rid of following birth, is a very rich stem cell source.
Objective: Cord blood collection gives no harm to the mother and baby. Besides, its allogeneic and autologous usage, the most important disadvantage is that the number of cells is insufficient in adults.
Conclusion: Today, it is predominantly used for therapeutic purposes for many diseases. The aim of this review is giving a detailed information about groups of stem cells in cord blood and determining the point of clinical use.
Export Options
About this article
Cite this article as:
Cavusoglu Turker *, Kilic Dogan Kubilay , Yigitturk Gurkan , Tomruk Canberk , Turgut Mehmet and Uyanikgil Yigit , Clinical Use and Patentability of Cord Blood, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2017; 11 (1) . https://dx.doi.org/10.2174/1872214812666180314121241
DOI https://dx.doi.org/10.2174/1872214812666180314121241 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Chemokine Receptors as Specific Anti-Inflammatory Targets in Peripheral Nerves
Endocrine, Metabolic & Immune Disorders - Drug Targets Endocrine Disruptors and Human Health
Mini-Reviews in Medicinal Chemistry The Pathogenic Subpopulation of Th17 Cells in Obesity
Current Pharmaceutical Design Drug Targets to Pro-Angiogenetic Factors with Special Reference to Primary Peritoneal Mesothelioma
Endocrine, Metabolic & Immune Disorders - Drug Targets Megsin Gene: Its Genomic Analysis, Pathobiological Functions, and Therapeutic Perspectives
Current Genomics Pancreatic Islets Under Attack: Cellular and Molecular Effectors
Current Pharmaceutical Design Human Umbilical Cord Mesenchymal Stem Cells Therapy for Insulin Resistance: A Novel Strategy in Clinical Implication
Current Stem Cell Research & Therapy Glycemic Variability and Insulin Needs in Patients with Type 1 Diabetes Mellitus Supplemented with Vitamin D: A Pilot Study Using Continuous Glucose Monitoring System
Current Diabetes Reviews Fluorinated Molecules as Drugs and Imaging Agents in the CNS
Current Topics in Medicinal Chemistry Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Anti-Cancer Agents in Medicinal Chemistry Radiolabeled Probes Targeting G-Protein-Coupled Receptors for Personalized Medicine
Current Pharmaceutical Design Effects of Adding Large Doses of Arachidonic Acid to Docosahexaenoic Acid on Social Impairment in Individuals with Autism Spectrum Disorders
Current Psychopharmacology Design and Synthesis of Thiazolidinedione Derivates as Selective PPARγ Modulators
Letters in Drug Design & Discovery Emerging Roles for Vasoactive Peptides in Diagnostic and Therapeutic Strategies Against Atherosclerotic Cardiovascular Diseases
Current Protein & Peptide Science Meet Our Editorial Board Member
Current Cancer Drug Targets Levels of Estrogen Receptors α and β in Frontal Cortex of Patients with Alzheimers Disease: Relationship to Mini-Mental State Examination Scores
Current Alzheimer Research Implications of CRISPR-Cas9 in Developing Next Generation Biofuel: A Mini-review
Current Protein & Peptide Science Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?
Current Vascular Pharmacology Alkaloids and Flavonoids as α1-Adrenergic Receptor Antagonists
Current Medicinal Chemistry Evaluation of Glucose and Lipid Lowering Activity of Arganimide A in Normal and Streptozotocin-Induced Diabetic Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets